BREAST CANCER STAGE I

This adverse event was reported 9277 times

These drugs are most commonly taken by patients reporting BREAST CANCER STAGE I:

# Drug Count
0 RANITIDINE 898
1 RANITIDINE HYDROCHLORIDE 451
2 INTERFERON BETA-1A 105
3 ADALIMUMAB 101
4 ETANERCEPT 88
5 ALENDRONATE SODIUM 71
6 METHOTREXATE SODIUM 69
7 FOLIC ACID 67
8 INFLIXIMAB 67
9 METHOTREXATE 64
See all common drugs associated with BREAST CANCER STAGE I

BREAST CANCER STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRICLOSAN 18 0.0312
1 CLEAR MINT, GEL TOOTHPASTE 14 0.0128
2 SODIUM FLUORIDE F18 14 0.0127
3 SODIUM FLUORIDE F-18 14 0.0126
4 HYDROCORTISONE SODIUM SUCCINATE 39 0.0098
5 RANITIDINE HYDROCHLORIDE 451 0.0083
6 SALICYLIC ACID 12% 15 0.0078
7 ASTRINGENT 15 0.0078
8 LIQUID CORN AND CALLUS REMOVER 15 0.0078
9 CLONIDINE HYDROCHLORIDE 38 0.0066
See all drugs enriched for association with BREAST CANCER STAGE I

BREAST CANCER STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 87 0.0029
1 Interleukin-5 Antagonist [EPC] 2 0.0029
2 Integrin Receptor Antagonist [EPC] 96 0.0011
3 Non-Standardized Plant Allergenic Extract [EPC] 17 0.0010
4 Antiparasitic [EPC] 3 0.0007
5 Pediculicide [EPC] 3 0.0006
6 Tetracycline-class Drug [EPC] 44 0.0006
7 Histamine-1 Receptor Antagonist [EPC] 50 0.0006
8 Interferon beta [EPC] 106 0.0006
9 Endoglycosidase [EPC] 1 0.0005
See all drug classes enriched for association with BREAST CANCER STAGE I